Senior insider sale
Chief Medical Officer at PROTAGONIST THERAPEUTICS, INC — senior position signals high conviction
$1.01M
12.23K shares
What this filing means
MOLINA ARTURO MD plans to sell 12.23K shares of PROTAGONIST THERAPEUTICS, INC valued at approximately $1.01M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/21/2026ACC: 0001104659-26-005438
Officer· Chief Medical Officer
Since Jan 2026
12.23K
Shares to sell
$1.01M
Approx. market value
9.51K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Services Rendered
1/20/2026
9.51KTotal acquired9.51K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/20/2026 | Restricted stock vesting under a registered plan Services Rendered | 9.51K | — |
| Total | 9.51K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.71K
Market value
$229.9K
11/17/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
9.51K
Market value
$784.7K
1/20/2026
Total
Units
12.23K
Value
$1.01M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/17/2025 | 2.71K | $229.9K | — | Completed |
| Planned — Approximate Date | ||||
1/20/2026 | 9.51K | $784.7K | NASDAQ | Planned |
| Total | 12.23K | $1.01M | ||